Richter BioLogics is a microbial CDMO and produces plasmid DNA in its GMP facilities for over 35 years. With our established ready to use proprietary process pART, we manufacture DNA for a wide range of applications including Cell & Gene Therapy (CGT), DNA Vaccines (API / Drug Substance production), critical raw material (CRM) as starting material for virus production (e.g. Lenti, AAV) or as starting material for mRNA production.
Flexibility makes the difference.
in 10 L
(non-GMP)
in 100 L
(DSP scales from 5 – 20g possible)
in 1.000 L
In addition to the methods listed, we provide further assays and custom developed procedures to meet your requirements.
Whether you require pDNA for clinical trial supply or at large-scale and for commercial supply, Richter BioLogics provides you with the most valuable plasmid DNA manufacturing services meeting all your requirements, specifications and timelines.
*Dependent on plasmid and product requirements.
With a structured and transparent quality approach we produce GMP plasmid DNA in GMP-certified manufacturing suites ensuring the requested quality. Our dedicated project management team guides and supports every client and their products throughout the whole project timeline. Close cooperation and honest partnerships are our claim to provide flexible and transparent services and best in class products.
The GMP manufacturing capacity at our three modern facilities ranges from 10 L to 1,500 L and includes end-to-end services along the whole value chain.
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information